Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Reconstitution of stem cells and enhancement of the barrier function of the gastrointestinal (GI) tract is critical to the resolution of intestinal acute graft-versus-host disease (aGvHD). Previously, our group has shown in murine models that type II innate lymphoid cells (ILC2) cells generate proteins in the GI tract that enhanced GI tract barrier function and diminished the expansion and function of pro-inflammatory donor cells when given to allogeneic stem cell transplant recipients. Therefore, the infusion of donor ILC2 cells could treat or prevent GI tract acute GvHD, but for this approach to be clinically applicable, robust expansion of a homogenous population of human ILC2 cells is needed. Here, we describe a method for the rapid expansion of a uniform population of human ILC2 cells which decrease GvHD in (NOD scid gamma mouse) NSG mice. The addition of IL-4 to the culture was critical to prevent the expansion of pro-inflammatory ILC1-like cells. Our approach should allow for the evaluation of human ILC2 cells to treat therapy-resistant GI tract acute GvHD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1182/bloodadvances.2024013609 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
IL-25-induced memory type 2 innate lymphoid cells enforce mucosal immunity.
Cell
September 2025
Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA. Electronic address:
Adaptation of intestinal helminths to vertebrates involved the evolution of strategies to attenuate host tissue damage to support parasite reproduction and dissemination of offspring to the environment. Helminths initiate the IL-25-mediated tuft cell-type 2 innate lymphoid cell (ILC2) circuit that enhances barrier protection of the host, although viable parasites can target and limit this pathway. We used IL-25 alone to create small intestinal adaptation, marked by anatomic and immunologic changes that persisted months after induction.
View Article and Find Full Text PDFα-Tocopherol ameliorates allergic airway inflammation by regulating ILC2 ferroptosis in an LKB1-dependent manner.
Mol Ther
September 2025
Pediatric Intensive Care Unit, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences); Department of Immunology, School of Basic Medical Sciences; Department of Clinical Laboratory, the Third Affiliated Hospital of Southern Medical University, Southern Medical University, Gua
Dietary immunization plays a pivotal role in modulating allergic airway inflammation mediated by group 2 innate lymphoid cells (ILC2s). This study identifies α-tocopherol (α-Toc), a component of vitamin E, as a key regulator of allergic airway inflammation. Transcriptomic analysis of lung ILC2s from mice treated with α-Toc reveals reduced expression of scavenger receptor class B type 1 (SCARB1) and inhibition of the liver kinase B1 (LKB1)-AMPK/mTOR signaling pathway.
View Article and Find Full Text PDFThe Expanding Role of ILC2s in Allergic Airways Disease.
Allergy
September 2025
Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, California, USA.
Group 2 innate lymphoid cells (ILC2s) play a pivotal role in the initiation and propagation of allergic airways disease. These cells, first discovered 15 years ago, respond to a range of stimuli in a non-antigen-dependent manner. ILC2s produce copious amounts of cytokines including IL-5 and IL-13, which are critical in the pathogenesis of allergic asthma.
View Article and Find Full Text PDFMALAT1 elevates the secretion of Th2 cytokines via miR-422a/NUP155 axis in allergic rhinitis mice.
Arch Biochem Biophys
August 2025
Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, 330006, China. Electronic address:
MALAT1 is one of the most well-studied lncRNAs in various diseases. This work attempted to investigate whether long non-coding RNA MALAT1 participate in the development of allergic rhinitis (AR). In this work, nasal mucosal tissues were obtained from AR patients.
View Article and Find Full Text PDFBCG Vaccine-Induced Innate and Adaptive Pulmonary Immunity Correlating with Protective Efficacy Against in the Lungs.
Vaccines (Basel)
August 2025
Department of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center, and the Louisiana Vaccine Center, New Orleans, LA 70112, USA.
Effective prophylaxis for (Mtb) requires greater understanding of immune correlates of protection. With renewed interest in BCG as an Mtb vaccine, particularly via the intravenous (IV) route, our objective was to characterize both innate and adaptive immune correlates of vaccine-induced pulmonary immunity as potential biomarkers for protective efficacy in a murine model of Mtb infection. Mice were given BCG via different routes and some boosted with recombinant virus constructs encoding Mtb Ag85B.
View Article and Find Full Text PDF